Publications Office of the EU
France-Poitiers: Research services - EU tenders
DisplayCustomHeader
MyPortal
Language Selector
English
BasketSummary
Procurement Detail Actions Portlet

Utilities

Procurement Detail Actions Portlet
OP Portal - Procurement - Details

France-Poitiers: Research services

Overview
  • Published
    01/02/2021
  • Deadline
    01/03/2021
  • Opening of tenders
    01/03/2021
  • Awarded
    06/05/2021
  • Today
    19/08/2026
Status
Awarded
Type of contract
Services
Subject for Renewal
Yes
Buyer
CHU de Poitiers
Place of performance
NUTS code: FR France
Location of buyer
NUTS code: FR France
Business sector (Main CPV)
73110000 Research services
Total estimated contract value (excluding VAT)
2,500,000.00 EUR
Total final contract value (excluding VAT)
2,856,000.00 EUR
Procedure details
Tender reference number
21S010
Description

Monitoring d'une étude clinique nationale en onco-hématologie.

Submission Method
Electronic via:
https://www.marches-publics.gouv.fr
Tenders may be submitted
Submission for all lots
Information about a public contract, a framework agreement or a dynamic purchasing system (DPS)
Not available
Conditions for opening tenders (date)
01/03/2021 17:00
Place of performance
FR France
CPV code

73110000 - Research services

Award method
The most economic tender
Estimated value
2,500,000.00 EUR
Final contracted value
2,856,000.00 EUR
Award of contract
Official name: Tempopharma, groupe Multihealth
Postal address: Vélizy Espace, 13 avenue Morane Saulnier
Town: Vélizy-Villacoublay
Postal code: 78140
Country: FRA
Documents
Prior information
Contract
Award
Footnote - legal notice

This content published on this page is meant purely as an additional service and has no legal effect. The Union's institutions do not assume any liability for its contents. The official versions of the relevant tendering notices are those published in the Supplement of Official Journal of the European Union and available in TED. Those official texts are directly accessible through the links embedded in this page. For more information please see Public Procurement Explainability and Liability notice.